Delveinsight Business Research Group
New Delhi, India· Est.
AI‑powered pharma intelligence and consulting firm delivering deep market and epidemiology insights across 27 therapeutic areas.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
AI‑powered pharma intelligence and consulting firm delivering deep market and epidemiology insights across 27 therapeutic areas.
OncologyRare diseasesCardiovascularNeurologyImmunologyInfectious diseases
Technology Platform
AI‑powered epidemiology intelligence platform (DelveEpiAI) that delivers natural‑language query responses, 10‑year disease burden forecasts, and structured market insights across multiple geographies.
Opportunities
Rapid expansion of AI‑driven pharma intelligence services and deeper penetration into emerging markets (APAC, LATAM, MENA) present significant growth avenues.
Risk Factors
Reliance on data quality and competition from larger analytics firms could impact market share and client retention.
Competitive Landscape
Competes with IQVIA, Decision Resources, and GlobalData; differentiates through AI‑enabled instant query capability and a strong focus on epidemiology‑centric forecasts.